{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:08:54Z","timestamp":1784689734354,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T00:00:00Z","timestamp":1399334400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Science","doi-asserted-by":"crossref","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.clinthera.2014.04.001","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T04:46:00Z","timestamp":1399265160000},"page":"722-736","source":"Crossref","is-referenced-by-count":49,"title":["Pharmacokinetics and Pharmacodynamics of Subcutaneous Recombinant Parathyroid Hormone (1\u201384) in Patients With Hypoparathyroidism: An Open-Label, Single-Dose, Phase I Study"],"prefix":"10.1016","volume":"36","clinical-trial-number":[{"clinical-trial-number":"nct00732615","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Bart L.","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene","family":"Kay Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Cyran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hjalmar","family":"Lagast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.04.001_bib1","unstructured":"National Organization for Rare Disorders. Hypoparathyroidism. http:\/\/www.rarediseases.org\/rare-disease-information\/rare-diseases\/byID\/703\/viewAbstract. Accessed January 21, 2014."},{"key":"10.1016\/j.clinthera.2014.04.001_bib2","first-page":"476","article-title":"Permanent postoperative hypoparathyroidism. An epidemiological clinical study using a new questionnaire instrument","volume":"9","author":"Bohrer","year":"2003","journal-title":"J Ukrainian Acad Sci"},{"key":"10.1016\/j.clinthera.2014.04.001_bib3","first-page":"2249","article-title":"Diseases of the parathyroid gland and other hyper- and hypocalcemic disorders","volume":"Vol 16","author":"Potts","year":"2005"},{"key":"10.1016\/j.clinthera.2014.04.001_bib4","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2014.04.001_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4158\/EP10302.RA","article-title":"Medical management of postsurgical hypoparathyroidism","volume":"17","author":"Khan","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinthera.2014.04.001_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Clinical practice. Hypoparathyroidism","volume":"359","author":"Shoback","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2014.04.001_bib7","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2014.04.001_bib8","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1210\/jc.2008-1216","article-title":"Hypoparathyroidism: is it time for replacement therapy?","volume":"93","author":"Horwitz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2014.04.001_bib9","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2014.04.001_bib10","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2014.04.001_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jc.2011-1908","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2014.04.001_bib12","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clinthera.2014.04.001_bib13","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2014.04.001_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomized, Phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clinthera.2014.04.001_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/jc.2012-2984","article-title":"Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2014.04.001_bib16","unstructured":"Fox J, Wells DS, Garceau RJ. Relationships between pharmacokinetic profile of human PTH (1-84) and serum calcium response in postmenopausal women following four different methods of administration. http:\/\/www.asbmr.org\/Meetings\/AnnualMeeting\/AbstractDetail.aspx?aid=cb1c7954-4672-41f1-8b55-9a70ec107b6f. Accessed January 21, 2014."},{"key":"10.1016\/j.clinthera.2014.04.001_bib17","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1016\/S0021-9258(19)81278-4","article-title":"Regulation of 25-hydroxyvitamin D3-1-hydroxylase in vivo","volume":"249","author":"Henry","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinthera.2014.04.001_bib18","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1016\/S0021-9258(19)81270-X","article-title":"Studies on calciferol metabolism. IX. Renal 25-hydroxy-vitamin D3-1 hydroxylase. Involvement of cytochrome P-450 and other properties","volume":"249","author":"Henry","year":"1974","journal-title":"J Biol Chem"},{"issue":"03_MeetingAbstracts","key":"10.1016\/j.clinthera.2014.04.001_bib19","article-title":"The effect of recombinant human parathyroid hormone (rhPTH[1-84]) on vitamin D metabolism: results from phase III REPLACE and phase I clinical studies","volume":"34","author":"Shoback","year":"2013","journal-title":"Endocr Rev"},{"issue":"03_MeetingAbstracts","key":"10.1016\/j.clinthera.2014.04.001_bib20","article-title":"The effect of recombinant human parathyroid hormone (rhPTH[1-84]) on phosphate homeostasis in patients with hypoparathyroidism","volume":"34","author":"Clarke","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clinthera.2014.04.001_bib21","first-page":"318","article-title":"Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients","volume":"54","author":"Block","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2014.04.001_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00223-006-0175-3","article-title":"Comparison of hypotensive response following intravenous injection of parathyroid hormone 1-84 and 1-34 in conscious rats","volume":"79","author":"Scott","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.clinthera.2014.04.001_bib23","first-page":"1356","article-title":"Effects of PTH(1-34) on blood pressure, renal function, and hormones in essential hypertension: the altered pattern of reactivity may counteract raised blood pressure","volume":"10","author":"Jespersen","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2014.04.001_bib24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI108831","article-title":"Nephrogenous cyclic adenosine monophosphate as a parathyroid function test","volume":"60","author":"Broadus","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2014.04.001_bib25","first-page":"974","article-title":"Urinary cyclic 3\u2019,5\u2019-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism","volume":"96","author":"Heath","year":"1980","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.clinthera.2014.04.001_bib26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jc.2006-1788","article-title":"Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis","volume":"92","author":"Antoniucci","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2014.04.001_bib27","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1210\/jc.2005-1712","article-title":"Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis","volume":"91","author":"Bauer","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2014.04.001_bib28","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00198-007-0336-x","article-title":"Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis","volume":"18","author":"Sellmeyer","year":"2007","journal-title":"Osteoporos Int"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814001957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814001957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:22:07Z","timestamp":1648927327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814001957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0149291814001957"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.04.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}